Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) represented a move of -13.47 percent or $0.36 per share and closed its previous day trading session at $3.79. 2.13 Million Shares were traded in the last trading session with an Average Volume of 404.02 Million Shares. The stock currently has a Market Capitalization of 204.6 Million.
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company’s drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
The stock traded between $3.24 and $9.75 over 1-Year time period showing its price to sales ratio of 5.4. Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-25.08 and 200-Day Simple Moving Average of $-37.55. Its Price to Free Cash Flow is 4.01 and Price to Book of 3.72.
Analyst’s recommended the stock as 1.4 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) reported its Actual EPS of $-0.11/share. The analysts offering Earnings Estimates for the company were believing that Pieris Pharmaceuticals, Inc. could bring EPS of $-0.12/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 8.3 Percent.
Synovus Financial Corp. (NYSE:SNV)
In the last trading session, Synovus Financial Corp. (NYSE:SNV) added its value by 0.24% closing at the price of $38.25. The stock currently has market capitalization of 4.48 Billion, with average volume of 1.62 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Synovus Financial Corp. (NYSE:SNV) is showing beta of 1.17. This particular value of beta suggests that Synovus Financial Corp. (NYSE:SNV) has historically moved 117% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Synovus Financial Corp. (NYSE:SNV) is at $3.21.
The stock currently has RSI of 30.71. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Synovus Financial Corp. is a financial services company and a registered bank holding company headquartered in Columbus, Georgia. The Company provides integrated financial services including commercial and retail banking, financial management, insurance and mortgage services to its customers through banking divisions of its wholly-owned subsidiary bank, Synovus Bank, and other offices in Georgia, Alabama, South Carolina, Florida and Tennessee. The Company’s relationship-driven community banking model is built on creating long-term relationships with our customers. This relationship banking approach allows its bankers to serve their customers’ individual needs and demonstrates its commitment to the communities in which it operate.
Synovus Financial Corp. (NYSE:SNV) topped its 52-week high price of $57.40 on 06/11/18 and 52-Week Low Price of $36.24 on 10/26/18. The Stock currently has P/E (price to earnings ttm) of 11.92 and Weekly volatility of 2.39% and monthly volatility of 3.37% respectively.